NCCN adds Natera's Signatera to bladder cancer treatment guidelines

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. WBD
4. AMD
5. USO
6. META
7. AMC
8. MSFT
9. ACN
10. AMZN

Go back to NCCN adds Natera's Signatera to bladder cancer treatment guidelines
(NASDAQ: NTRA) Delayed: 369.17 -0.22 (0.06%)
Previous Close $369.39    52 Week High $13.80 
Open $371.92    52 Week Low $6.52 
Day High $371.92    P/E N/A 
Day Low $363.96    EPS $0.00 
Volume 350,455